Contents start

Corporate Profile

Company name Olympus Terumo Biomaterials Corp.
Representative Hiroshi Hashimoto, President
Head Office Sasazuka NA Bldg., 1-50-1 Sasazuka, Shibuya-ku, Tokyo 151-0073, Japan

Map

Business activities Research and development relating to biomaterials and regenerative medicine, including ceramic bone substitute and collagen, and manufacture and sales of these products
Capitalization 72,070,000 yen
Ownership Olympus 66.6%(192,000 shares), Terumo 33.4%(96,290 shares)
Business commencement Octoberber 1, 2004
Employees 140 (as of April 1,2019)
Officers
President Hiroshi Hashimoto
Vice President Norio Yoda
Director Toshihiko Okubo
Director Manabu Ishikawa
Director Toshihiko Osada
Director Ryoichi Kono
Auditor Masashi Shimizu
Auditor Naoki Muto
Financing bank Sumitomo Mitsui Banking Corporation

Company History

September 2004 Established Olympus Biomaterial Corp.
September 2005 Acquired HAp technologies from Sumitomo Osaka Cement Co., Ltd.
December 2006 Concluded the joint venture agreement with Terumo Corporation.
January 2007 Opened the manufacturing facility in Mishima, Shizuoka
April 2007 Changed the name to Olympus Terumo Biomaterials Corp.
December 2007 Acquired ISO 13485 certification
July 2009 Opened Logistics Center in Shinagawa, Tokyo
February 2015 Concluded an exclusive distribution agreement with Alcare Corporation for artificial dermis (medical applications)
May 2015 Opened the second Logistics Center in Fukuoka, Kyushu
June 2015 Launched our own HTO Plate System successfully, expanding the portfolio of the orthopedic metal implants
February 2016 Moved the Head Office to Sasazuka, Tokyo

Start of sitemap and about this website menus